Serine protease HTRA1 antagonizes transforming growth factor-β signaling by cleaving its receptors and loss of HTRA1 in vivo enhances bone formation - Wikidata - wikimedia - TriplyDB

Serine protease HTRA1 antagonizes transforming growth factor-β signaling by cleaving its receptors and loss of HTRA1 in vivo enhances bone formation

Serine protease HTRA1 antagonizes transforming growth factor-β signaling by cleaving its receptors and loss of HTRA1 in vivo enhances bone formation

http://www.wikidata.org/entity/Q34989757

about

Age-related neurogenesis decline in the subventricular zone is associated with specific cell cycle regulation changes in activated neural stem cells Synonymous variants in HTRA1 implicated in AMD susceptibility impair its capacity to regulate TGF-β signaling.Cerebral small vessel disease: insights and opportunities from mouse models of collagen IV-related small vessel disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signaling Proteomics analysis of the zebrafish skeletal extracellular matrix.Restoration of mesenchymal retinal pigmented epithelial cells by TGFβ pathway inhibitors: implications for age-related macular degeneration High temperature requirement A1, transforming growth factor beta1, phosphoSmad2 and Ki67 in eutopic and ectopic endometrium of women with endometriosis.Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain?Genetic factors in cerebral small vessel disease and their impact on stroke and dementia.RNA Interference and BMP-2 Stimulation Allows Equine Chondrocytes Redifferentiation in 3D-Hypoxia Cell Culture Model: Application for Matrix-Induced Autologous Chondrocyte Implantation Role of HTRA1 in bone formation and regeneration: In vitro and in vivo evaluation.Molecular cloning, expression, and anti-tumor activity of a novel serine protease from Arenicola cristata.Tumor-Suppressor Inactivation of GDF11 Occurs by Precursor Sequestration in Triple-Negative Breast Cancer.High-Temperature Requirement A1 (Htra1) - A Novel Regulator of Canonical Wnt Signaling.HtrA1 may regulate the osteogenic differentiation of human periodontal ligament cells by TGF-β1.

P2860

Q27346913-F5C86DD7-E5C0-4355-8E1D-7D01B935ED13 Q30378420-875E62D2-94ED-4173-A6C8-A0DCBB38389C Q30574731-CBD109EE-8346-480F-943E-153698EEC1EB Q34581220-2F51755F-DBC8-4D5C-A9E2-A9E665B9371C Q35114668-61049DFA-2C64-453D-9793-64F46BE2C929 Q35819298-60C98662-AC53-40E6-98B7-D57E6D941CA8 Q36423105-5B42A2AA-41EE-4500-B503-F534884500FE Q36593214-2030C1BF-BAE6-491E-B6F5-6661BD52A6FA Q38433566-88A61F62-3246-4F1B-9228-4954AAF04C95 Q38610396-1CEA4694-B065-4D7A-8CB0-FEC9E76DB764 Q38696646-A24BF907-9272-4227-80D6-D8BED7579549 Q42653146-A72228B3-5B52-4FF7-8CAB-DC62E619D13F Q45073569-FC4A4E70-0CDB-4D8C-B024-7B2FD8E5B3BE Q47139136-7DF1A2F7-9D52-4F43-8237-9DE7CBB0AF65 Q52963267-E09A35FE-37D0-4AEF-A639-0A7E32B9CC57

P2860

Serine protease HTRA1 antagonizes transforming growth factor-β signaling by cleaving its receptors and loss of HTRA1 in vivo enhances bone formation

http://www.wikidata.org/entity/Q34989757

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@ast

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@en

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@nl

type

label

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@ast

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@en

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@nl

prefLabel

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@ast

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@en

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@nl

P1433

Q34989757-43100735-8C68-4F3F-A2E7-42A08329CF5A

P1476

Q34989757-76AE9ADF-E485-4CE8-9247-E53CFF145CBF

P2093

Q34989757-10E6B5B3-FD02-4CB6-8584-45F9FFE43AA0

Q34989757-1A0ABE47-4FB7-42AC-983C-C3D919D4CEEF

Q34989757-4366D0D9-8A56-4061-AF35-CAA13550A522

Q34989757-5E320E1E-F41D-4E74-92F6-7956EFAB856E

Q34989757-6108A354-01B6-4B1E-A8F8-9FFFB56D7E76

Q34989757-72C841A5-5C59-4295-A7C1-DBF52BFC94D1

Q34989757-A4441DA6-BAF5-4C3D-B5DB-8F766559D614

Q34989757-BB61F088-873D-4D06-96FB-AB0F5E4A7E34

Q34989757-DDAD84A8-3F42-4B46-8556-C16F90169203

Q34989757-ED866D83-9FB8-4A78-89DB-C77B44728155

P2860

Q34989757-0993E9F7-D4E9-4A26-BDBC-3B82D467287C

Q34989757-0ED093E6-0692-4159-BF37-D1B0066700C7

Q34989757-1D769D82-1FCC-4085-9127-579B2C2035B9

Q34989757-1D93959A-576C-47EB-BED8-A2FD902CC6A3

Q34989757-2DDF35A9-8AB5-4A45-BA68-DB316C525A90

Q34989757-30343957-A4FA-4EB8-938A-77C6D167A769

Q34989757-40EE1C3D-9724-46B7-822E-A33795C95158

Q34989757-485458CE-17E6-40F7-9D94-1CEB38AA0826

Q34989757-52D64DF3-3775-45A7-A820-81A87413AE06

Q34989757-5386A680-891F-4318-B699-A888B2AF16B9

P304

Q34989757-C9EB7F87-0552-43A9-B6D9-1E84D3DDFEA9

P31

Q34989757-A2464235-9C01-43F4-BE5E-30FF550BDD94

P356

Q34989757-A2CA3CE5-9465-4C6D-ADFF-3265359C3BF9

P407

Q34989757-35F0FE68-FEF9-44D9-9AB5-370DE1C0CF3C

P433

Q34989757-79286A16-C707-4CEC-A9AF-81B6BF5072E1

P478

Q34989757-81D86D84-479A-4665-A13B-37DC83149D16

P577

Q34989757-50C685F5-2DC7-459E-90C1-19EC738E1496

P5875

Q34989757-172F75C2-A8EC-4728-BBDB-3318161CBD29

P698

Q34989757-5FA4A860-3540-4DCB-A600-BBF362C442FB

P932

Q34989757-8DBC2B2A-D5E9-4271-A8FB-A7667090330D

P356

JOURNAL.PONE.0074094

P1433

P1476

Serine protease HTRA1 antagoni ...... n vivo enhances bone formation

@en

P2093

Angela Chamberland

http://www.w3.org/2001/XMLSchema#string

Carl R Flannery

http://www.w3.org/2001/XMLSchema#string

David Dai

http://www.w3.org/2001/XMLSchema#string

Julie R Graham

http://www.w3.org/2001/XMLSchema#string

Mark S Ryan

http://www.w3.org/2001/XMLSchema#string

Moisés A Rivera-Bermúdez

http://www.w3.org/2001/XMLSchema#string

Qingcong Lin

http://www.w3.org/2001/XMLSchema#string

Weilan Zeng

http://www.w3.org/2001/XMLSchema#string

X Jian Li

http://www.w3.org/2001/XMLSchema#string

Zhiyong Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage

Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins

HTRA1 promoter polymorphism in wet age-related macular degeneration

Primary structure of a putative serine protease specific for IGF-binding proteins

Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF-beta signaling

Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones

Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components

TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor

P304

e74094

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0074094

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256614473

http://www.w3.org/2001/XMLSchema#string

P698

24040176

http://www.w3.org/2001/XMLSchema#string

P932

3770692

http://www.w3.org/2001/XMLSchema#string